Minnesota
Gov. Tim Walz (D) issued an executive order (EO) to address the state’s intention to ensure that vaccine access is preserved and expanded. The EO directs various government agencies to investigate ways to expand access to payment for vaccines. NACDS intends to work with members and state partners to advocate for strengthening pharmacy vaccine reimbursement.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Pennsylvania
In the wake of the massive pharmacy closures across the Commonwealth, the Senate Pharmacy Caucus held a briefing this week to discuss the crisis and examine models to reform Medicaid Managed Care pharmacy reimbursement that received widespread press coverage. NACDS and PACDS were heavily involved in preparation for the briefing, including drafting questions, providing supporting materials and meeting directly with the Senators and senior staff. Following the Department of Human Services' (DHS') testimony, the Senators, led by Caucus Chairs Judy Ward (R), Lisa Boscola (D) and Tina Tartaglione (D), aggressively grilled Secretary Val Arkoosh. They expressed strong exception to the Secretary's testimony that downplayed the role of Medicaid rates on pharmacy closures; their lack of awareness that chains operating in the greater Philadelphia metro area are receiving a $1.00 professional dispensing fee after the health plan raised it to $3.00 for independents; the fact that they are approving rates that don't comply with their MCO contract terms that require both the ingredient cost and professional dispensing fee to reflect pharmacies' actual costs. NACDS participated in the Pennsylvania Pharmacy Coalition panel that testified next, dismissing DHS' points and emphasizing that immediate pharmacy reimbursement is critical to protect patients' access to medications and healthcare services. Senators Ward and Boscola will soon introduce legislation backed by the Pennsylvania Pharmacy Caucus and drafted by NACDS, to require cost-based reimbursement under a non-conflicted, transparent single PBM model.
Also in Pennsylvania, a group of House Democratic health professionals announced that they introduced legislation that would protect Pennsylvanians' access to recommended vaccines. HB 1828 would require private insurers to cover vaccines that have been recommended by the Pennsylvania Department of Health, based on the vaccine guidelines of professional medical societies, including the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American College of Physicians, the American Academy of Family Physicians, the Infectious Diseases Society of America and the Society for Maternal-Fetal Medicine.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
South Carolina
Gov. Henry McMaster (R) has issued an executive order prohibiting the use of SNAP (Supplemental Nutrition Assistance Program) benefits to purchase candy, energy drinks, soft drinks and other sweetened beverages. The order directs the Department of Social Services to submit a waiver request to the USDA Food and Nutrition Service to implement the policy.
The executive order also provides specific definitions for candy, energy drinks, soft drinks and sweetened beverages, while outlining certain exceptions.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Tennessee
Effective October 1, TennCare will cover OTC medications and supplements at a GPI (generic product identifier) level rather than by specific NDCs. Please review this document for additional information and instructions on how to dispense such products.
Also in Tennessee, TennCare distributed an updated Preferred Drug List (PDL) that was effective on September 1. Additional TennCare updates are available online. Subscribe to the TennCare Pharmacy Updates newsletter to receive updates directly from TennCare.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Virginia
On September 10, the Department of Health issued a standing order authorizing the dispensing and administration of COVID vaccines to adults.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Colorado
The Department of Public Health Environment issued a Public Health Order and Standing Order today to address COVID-19 vaccine administration. These orders enable all vaccine providers to administer these vaccines in accordance with the Standing Order, eliminating the need for additional prescriptions. In addition to the Public Health Order and Standing Order, the Colorado State Board of Pharmacy will engage in emergency rulemaking on Friday, September 5, to adopt changes to Rule 3 and 19 to allow for continuity of vaccinations, especially COVID, thus ensuring that pharmacists, pharmacy interns, and pharmacy technicians may continue to prescribe, dispense and administer vaccinations in accordance with applicable Colorado Revised Statutes.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Florida
Under Constitutional Amendment No. 2, approved by voters in 2020, Florida's minimum wage will rise again this fall. Beginning September 30, 2025, the state minimum wage will increase from $13.00 to $14.00 per hour.
The amendment requires annual increases until the rate reaches $15.00 per hour by September 30, 2026. This applies to all employers in Florida—public and private—regardless of size.
Employers must also update required workplace postings to reflect the new wage. Updated posters will be made available for download once released.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Illinois
Gov. J.B. Pritzker (D) has signed HB3637, authorizing health care professionals to prescribe any drug approved by the FDA before 2025 that continues to carry World Health Organization approval. The law is designed to safeguard access to abortion medication in the event of future FDA restrictions.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Indiana
The Family and Social Services Administration (FSSA) Medicaid announced that based on the results of a recent cost of dispensing survey, they plan to reduce the dispensing fee by 8%, lowering it from $10.48 to $9.63, effective March 1, 2026. NACDS will submit comments by September 19, 2025, the deadline, and encourages members to do so too.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Massachusetts
The Department of Public Health has recently issued a standing order allowing for all qualified pharmacy personnel at Massachusetts pharmacies to dispense and administer COVID-19 vaccine in Massachusetts to all eligible persons.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Mississippi
Effective October 1, 2025, House Bill 1463 requires all sellers of pseudoephedrine products in the state to participate in the NPLEx electronic tracking system. Products from manufacturers that do not participate will no longer be processed through NPLEx after that date.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
North Carolina
Effective Sept. 28, 2025, NCTracks is implementing a new attestation process for Individual and Atypical Individual providers as part of initial enrollment, re-enrollment and reverification applications submitted through the secured provider portal of NCTracks. This change aligns with the National Committee for Quality Assurance (NCQA) standards.
Also in North Carolina, NCTracks will capture an Individual provider's race, ethnicity, and languages spoken during Individual provider enrollment, re-enrollment, manage change requests, and reverification applications.
Responses will not be shared outside of the North Carolina Department of Health and Human Services and will be used only for internal purposes.
For questions, please contact the NCTracks Contact Center at 1-800-688-6696.
Also in North Carolina, the Board of Pharmacy has published its list of seven pages of rules and determined that every one of these rules are necessary except for some rules dealing with administrative or operational conduct of the Board of Pharmacy. These rules are not being amended but are being readopted, as necessary. The comment period ends for these rules on Thursday, September 11, 2025. Here is a link to all of the rules under review .
Any person wishing to submit public comments must do so by September 11, 2025. Submit written comments by mail to Jay Campbell, Executive Director, North Carolina Board of Pharmacy, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517; by fax (919) 246-1056; or by e-mail ncboprulemaking@ncbop.org.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Texas
The second 30-day special legislative session convened on August 26, 2025.
Also in Texas, HB 25, legislation allowing pharmacists to dispense ivermectin without a prescription, was signed into law by Gov. Greg Abbott (R). The bill requires the Board of Pharmacy (TSBP) to adopt standardized procedures and protocols for pharmacists to follow.
Also in Texas, HB 7, legislation that strengthens existing law on abortion-inducing drugs, will allow private citizens to sue anyone who manufactures, distributes, mails or provides abortion medication to or from Texas, passed the House and is awaiting final approval in the Senate before heading to Gov. Greg Abbott's (R) desk.
Finally in Texas, HB 4535, which passed during the regular session and went into effect on September 1, 2025, is aimed at ensuring that Texans are equipped with the information they need to make informed medical decisions by requiring written informed consent prior to any COVID-19 vaccination. The Department of State Health Service (DSHS) created a COVID-19 Vaccine Information Statement to be used as a handout at the pharmacy to comply with the law.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
The Board of Pharmacy provided the following August 26, 2025, Update. It is being shared here in its entirety.
California Medication Error Reporting (CAMER)
Pursuant to Business and Professions Code section 4113.1
Business and Professions Code (BPC) section 4113.1 establishes requirements for a community pharmacy to report medication errors to an entity approved by the Board. The Board refers to this as the California Medication Error Reporting (CAMER) system. The statute requiring reporting to CAMER can be viewed at BPC section 4113.1.
In September 2024, the Board approved the Institute for Safe Medication Practices (ISMP), an ECRI Company, as the entity to receive and review medication error reports under BPC section 4113.1. Consistent with its commitment to keep licensees apprised of implementation activities, in April 2025, the Board announced the availability of information about how community pharmacies can register with ISMP to report medication errors to the California Medication Error Reporting (CAMER) system. To continue its communication with licensees, the Board advises licensees that medication errors that occur on or after September 1, 2025, must be reported to the CAMER system consistent with legal requirements established.
The API to allow for direct, electronic submission of medication errors to the California Medication Error Reporting (CAMER) systems will be available beginning Friday, August 29. 2025. If you are interested in implementing the API in your internal reporting system, please email the Institute for Safe Medication Practices at: clientservices@ecri.org.
For individual pharmacies that want to implement the API, please include the following information in your communication:
- Pharmacy name (as listed on the pharmacy license)
- Pharmacy license number
- Please confirm that this is for an individual pharmacy and the pharmacy is not part of a parent organization who will be reporting on behalf of the pharmacy
For organizations and Patient Safety Organizations (PSO) that will implement the API to report on behalf of multiple pharmacies, we will need to understand the hierarchy or relationships between individual pharmacies and the parent organization and/or PSO. Please include the following information in your communication:
- Name of the parent organization and/or PSO
- A list of the pharmacies on whose behalf you will be reporting
- Please provide both the pharmacy names (as listed on the pharmacy license) and license numbers
- Please provide details as to the relationship between the individual pharmacies, any multi-pharmacy organizations, and your organization
Once we confirm the above information and the correct relationships, if any, between individual pharmacies and parent organizations is established, an API key to use for testing purposes during the organization’s internal development process will be issued via encrypted email.
When the organization has completed their internal development and testing, they can contact ISMP for a new API key to use for submission of medication error reports. The API used during development and testing will be discontinued.
The API technical documentation to use for development will be posted by Friday, August 28, 2025 in the Frequently Asked Questions section at: https://mederrors.ismp.org/products/ca-board-of-pharmacy-error-reporting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Colorado
The Prescription Drug Affordability Board (PDAB) is seeking comments on its proposal to cap payment for the drug Enbrel at the Medicare price. Enbrel is one of the first Medicare Part D 10 drugs to be included in the Medicare Drug Price Negotiation Program (MDPNP) beginning January 1, 2026. Rulemaking for Enbrel began in May, and the rulemaking hearings continued on upper payment limit (UPL) for Enbrel in July and August. The fourth and possibly final rulemaking hearing on UPL for Enbrel will be on October 3.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Delaware
On August 25, Gov. Matt Meyer (D) signed SJR 7, an act authorizing the State Employees Benefits Committee (SEBC) to utilize specific strategies and policies when interacting and contracting with PBMs in order to achieve lower cost pharmaceutical drug benefit plans for the state. NACDS supported this legislation during the 2025 session and will continue to support PBM legislation and enforcement in Delaware.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Indiana
Earlier this year, pharmacies successfully passed SB 140, legislation that included a provision tying the commercial dispensing fee rates to Medicaid’s fee-for-service (FFS) rates as a minimum floor. Unfortunately, the Family and Social Services Administration (FSSA) announced last week that, based on the results of a recent cost of dispensing survey, Medicaid plans to reduce the dispensing fee by 8%, lowering it from $10.48 to $9.63, effective March 1, 2026. NACDS will submit comments by September 19 deadline and encourages members to do so as well.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Maine
On August 26, the Department of Professional and Financial Regulation, Bureau of Insurance, held a hearing on proposed rule change to define and prohibit spread pricing. NACDS attended the hearing and submitted testimony in support of the proposed changes. Additional written comments are due by September 9 at 4:00 p.m. and should be addressed to: Karma Lombard, Maine Bureau of Insurance, 34 State House Station, Augusta, Maine 04333 or Karma.Y.Lombard@maine.gov.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Maryland
The Prescription Drug Affordability Board published a notice that they will be holding two Zoom informational hearings on September 3 to receive input, information and opinions from the public and stakeholders to assist the Board in developing policy to address the affordability challenges created by the use of Farxiga and Jardiance. Details are available in the notice.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Also in Maryland, on August 27, the Insurance Administration (MIA) and Medicaid hosted the inaugural meeting of a workgroup to study PBM practices in both Medicaid and the commercial market. NACDS is serving on the panel, which already has four meetings scheduled for this fall. The department leads presented slides outlining the workgroup composition, schedule, expectations, goals and timeline.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Massachusetts
In this month’s Pharmacy Facts, published by MassHealth, they provided an update to the vaccine administration fee.
In accordance with 101 CMR 317.03(5): Allowable Fee for Certain Eligible Providers, payment for services provided by pharmacies that utilize pharmacists, or other health care professionals certified in accordance with 105 CMR 700.00: Implementation of M.G.L. c. 94C, is 85% of the allowable fee set forth in 101 CMR 317.04: Maximum Allowable Fees – Medical Services.
Following the pricing methodology cited above, for pharmacies that utilize pharmacists, or other health care professionals certified in accordance with 105 CMR 700.00: Implementation of M.G.L. c. 94C, the administration fee for vaccines other than COVID-19 is $17.38. The administration fee for COVID-19 vaccines is $38.21. Starting August 22, these rates were reflected on all such claims.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
New York
On August 21, NYRx, the New York State Medicaid Prescription Drug Program, announced an update to its Preferred Drug Program (PDP).
Also in New York, the State Department of Health Office of Health Insurance Programs released a Medicaid update. This update includes a reminder of 90-day prescriptions for most maintenance medications and OTC drugs. The update also includes a notice that NYRx now accepts electronic prior authorizations through CoverMyMeds.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Alaska
The Board of Pharmacy’s next quarterly meeting will be held virtually only on August 21. The Zoom log-in information, tentative agenda and public meeting packet are available on the board’s webpage. The public will need to register in advance using the link provided on the agenda. If you plan to testify on a subject, you must select “yes” in the questions when registering.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
The Department of Health Care Service posted the following alert on the Medi-Cal Rx Web Portal: Now Active: Changes to Remittance Advice.
Also in California, continuing collaborative efforts, the Board of Pharmacy and the Veterinary Medical Board are working to schedule a forum for stakeholder engagement to discuss crosscutting issues. To ensure interested stakeholders are kept apprised of these efforts, the Board is establishing an interested parties list. Please email rxwebmaster@dca.ca.gov to be added to the email distribution list specific to this forum.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Florida
House Speaker Danny Perez (R) has invited lawmakers to join a committee to examine potential mid-decade redistricting. Perez said the House lacks the time and resources to hold a special session but wants the committee to convene in October during the scheduled interim committee meeting period.
Also in Florida, Attorney General James Uthmeier (R) has issued an emergency rule prohibiting 7-OH, a concentrated byproduct of kratom. Physicians caution that the substance is as addictive as opioids. Joining Uthmeier for the announcement, FDA Commissioner Mark Makary warned that kratom could signal the fourth wave of the opioid epidemic.
Finally, the Department of Revenue has released Tax Information Publication (TIP), titled "Sales Tax on Commercial Rentals Repealed Effective October 1, 2025." Effective October 1, the state sales tax imposed on rent or license fees for the use of real property (commercial rentals) under section 212.031, Florida Statutes (F.S.), is repealed. This means no state sales tax or discretionary sales surtax applies to rent or license fees for rental or occupancy periods beginning on or after October 1, 2025. Examples of commercial rentals subject to the repeal include rentals of commercial office or retail space, warehouses and self-storage units. This publication provides important guidance regarding the upcoming repeal of sales tax on commercial rentals. We encourage you to review the TIP for details on how this change may affect your business or operations.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Indiana
The Health Coverage Programs (IHCP) posted several important provider bulletins of interest to pharmacies:
- BT2025117 – Pharmacy updates approved by the Office of Medicaid Policy and Planning August 2025 on Ordering, Prescribing or Referring; Pharmacy/Prescribing, Physician/Practitioner
- BT2025112 – Pharmacy updates approved by Drug Utilization Review Board July 2025
- BT2025107 – Final Notice: Gainwell mail forwarding expired on August 1, 2025
For more information, contact NACDS’ Mary Staples at 817-442-1155.